| ||
| Slide 1 2004: FDA approves second targeted drug, erlotinib, for non-small cell lung cancer. 2004-2005: Adjuvant therapy proven effective in lung cancer ... www.cancerprogress.net/.../progress_against_lung_cancer_slid... | ||
| Results of three Phase II Trials in Lung Cancer Indications ... In non-small cell lung cancer, the first evaluation of the randomised Phase ... for the treatment of relapsed small-cell lung cancer (ASCO abstract 7077). ... biotech.einnews.com/.../437206-results-of-three-phase-ii-trials... |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment